Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
EA
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.2% |
| 2 | Technology | 14.19% |
| 3 | Financials | 12.33% |
| 4 | Consumer Staples | 10.22% |
| 5 | Industrials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Flexsteel Industries
FLXS
$300M
| $2.61M | ﹤0.01% |
48,300
| – | – |
|
2102
Southern Missouri Bancorp
SMBC
$846M
| $2.61M | ﹤0.01% |
81,034
+13,734
| +20% | +$453K |
|
|
XRM
2103
DELISTED
Xerium Technologies Inc (new)
XRM
| $2.61M | ﹤0.01% |
363,200
+32,700
| +10% | +$227K |
|
|
PPL
2104
PPL Corp
PPL
$27.1B
| $2.6M | ﹤0.01% |
+67,300
| New | +$2.6M |
|
|
GURE
2105
Gulf Resources
GURE
$4.85M
| $2.6M | ﹤0.01% |
32,678
+998
| +3% | +$88.7K |
|
|
QVCGA
2106
DELISTED
QVC Group Inc Series A
QVCGA
| $2.6M | ﹤0.01% |
2,180
-21,894
| -91% | -$24.2M |
|
2107
Manulife Financial
MFC
$73.6B
| $2.59M | ﹤0.01% |
137,924
-922,000
| -87% | -$16.3M |
|
|
ALO
2108
DELISTED
Alio Gold Inc
ALO
| $2.58M | ﹤0.01% |
569,401
+79,649
| +16% | +$367K |
|
2109
Huron Consulting
HURN
$2.43B
| $2.58M | ﹤0.01% |
59,668
-45,398
| -43% | -$1.95M |
|
|
CTG
2110
DELISTED
Computer Task Group, Inc.
CTG
| $2.58M | ﹤0.01% |
461,200
+33,200
| +8% | +$187K |
|
|
CAI
2111
DELISTED
CAI International, Inc.
CAI
| $2.58M | ﹤0.01% |
109,200
+50,300
| +85% | +$1M |
|
2112
Equity Bancshares
EQBK
$1.07B
| $2.55M | ﹤0.01% |
83,300
-28,900
| -26% | -$894K |
|
|
SBNY
2113
DELISTED
Signature Bank
SBNY
| $2.55M | ﹤0.01% |
17,774
-206,400
| -92% | -$29.3M |
|
|
WMAR
2114
DELISTED
West Marine Inc
WMAR
| $2.55M | ﹤0.01% |
198,400
-54,400
| -22% | -$547K |
|
|
PNTR
2115
DELISTED
Pointer Telocation Ltd.
PNTR
| $2.55M | ﹤0.01% |
219,640
+27,540
| +14% | +$283K |
|
|
BCRH
2116
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
| $2.55M | ﹤0.01% |
139,123
+9,443
| +7% | +$177K |
|
|
SNT
2117
Senstar Technologies
SNT
$42.9M
| $2.53M | ﹤0.01% |
514,949
-12,000
| -2% | -$70.6K |
|
2118
Agilysys
AGYS
$3.2B
| $2.53M | ﹤0.01% |
250,200
+24,200
| +11% | +$235K |
|
2119
Graco
GGG
$13.3B
| $2.52M | ﹤0.01% |
+69,300
| New | +$2.46M |
|
|
CHUBA
2120
DELISTED
CommerceHub, Inc. Series A Common Stock
CHUBA
| $2.52M | ﹤0.01% |
144,900
+38,800
| +37% | +$639K |
|
2121
Ollie's Bargain Outlet
OLLI
$4.62B
| $2.52M | ﹤0.01% |
+59,200
| New | +$2.32M |
|
|
DEST
2122
DELISTED
Destination Maternity Corporation
DEST
| $2.52M | ﹤0.01% |
780,900
+26,100
| +3% | +$106K |
|
2123
BCB Bancorp
BCBP
$163M
| $2.52M | ﹤0.01% |
164,661
+37,561
| +30% | +$590K |
|
|
TIER
2124
DELISTED
TIER REIT, Inc.
TIER
| $2.52M | ﹤0.01% |
136,300
+76,200
| +127% | +$1.31M |
|
2125
National Bankshares
NKSH
$271M
| $2.52M | ﹤0.01% |
61,700
-1,500
| -2% | -$61.5K |
|
Similar funds
Jim Simons's Q2 2017 Portfolio in Review
As of Q2 2017, Jim Simons held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Jim Simons deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Jim Simons's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Jim Simons added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Jim Simons's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Jim Simons fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Jim Simons's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Jim Simons opened 398 new positions and closed 418 in Q2 2017.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.